Stella Biotechnologies Presented Research on Nanofiltration Development

Biotech Investing

Stellar Biotechnologies, Inc (NASDAQ:SBOT, TSXV:KLH) presented scientific research on nanofiltration development at last week’s PepTalk: The Protein Science Week Conference, in San Diego, California, Jan 18-22, 2016.

Stellar Biotechnologies, Inc (NASDAQ:SBOT, TSXV:KLH) presented scientific research on nanofiltration development at last week’s PepTalk: The Protein Science Week Conference, in San Diego, California, Jan 18-22, 2016.
According to the company’s press release:

The research poster presentation, titled “Development of a 20N Virus Filtration Process for Keyhole Limpet Hemocyanin (KLH) – A High Molecular Weight Protein,” was authored by Stellar scientists Catherine Brisson, Ph.D., Laura Milbrandt, Zully Aguilar, and William Bailey. The presentation reported data from the Company’s development and validation of filtration methods for the removal of viruses during manufacturing processes of KLH products.

Click here to view the full press release. 

The Conversation (0)
×